Mircea Balasa
Overview
Explore the profile of Mircea Balasa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perez-Millan A, Lal-Trehan Estrada U, Falgas N, Guillen N, Borrego-Ecija S, Junca-Parella J, et al.
Eur Radiol
. 2025 Feb;
PMID: 39934339
Objectives: Frontotemporal dementia (FTD) usually shows more asymmetric atrophy patterns than Alzheimer's disease (AD). We aim to quantify this asymmetry to differentiate FTD, AD, and FTD subtypes. Methods: We studied...
2.
Naranjo L, Sarto J, Nos C, Alcolea D, Rodriguez-Baz I, Navalpotro-Gomez I, et al.
J Neurol
. 2025 Feb;
272(3):198.
PMID: 39932589
Discrepancies in results between cerebrospinal fluid (CSF) 14-3-3 protein and prion protein detection using real-time quaking-induced conversion (RT-QuIC) might limit the confidence in ante-mortem clinical diagnosis of sporadic Creutzfeldt-Jakob disease...
3.
Sarto J, Esteller-Gauxax D, Guillen N, Falgas N, Borrego-Ecija S, Massons M, et al.
J Neurol
. 2025 Jan;
272(2):160.
PMID: 39849125
Plasma tau phosphorylated at threonine 181 (p-tau181) and 217 (p-tau217) have demonstrated high accuracy for Alzheimer's disease (AD) diagnosis, defined by CSF/PET amyloid beta (Aβ) positivity, but most studies have...
4.
Borrego-Ecija S, Junca-Parella J, Vandebergh M, Perez Millan A, Balasa M, Llado A, et al.
Neurology
. 2024 Nov;
103(11):e209944.
PMID: 39527772
Background And Objectives: Pathogenic variants in the gene cause frontotemporal dementia (FTD-) with marked brain asymmetry. This study aims to assess whether the disease progression of FTD- depends on the...
5.
Montagut N, Borrego-Ecija S, Herrero J, Castellvi M, Balasa M, Llado A, et al.
J Speech Lang Hear Res
. 2024 Sep;
67(10):3762-3777.
PMID: 39302879
Purpose: Primary progressive aphasia (PPA) is a neurodegenerative disorder characterized by worsening of speech and/or language. Script training intervention promotes automatized speech production via repeated practice of scripted content. This...
6.
Perez-Millan A, Thirion B, Falgas N, Borrego-Ecija S, Bosch B, Junca-Parella J, et al.
Neurobiol Aging
. 2024 Sep;
144:1-11.
PMID: 39232438
Neuroimaging and fluid biomarkers are used to differentiate frontotemporal dementia (FTD) from Alzheimer's disease (AD). We implemented a machine learning algorithm that provides individual probabilistic scores based on magnetic resonance...
7.
Munoz-Lopetegi A, Baiardi S, Balasa M, Mammana A, Maya G, Rossi M, et al.
NPJ Parkinsons Dis
. 2024 Aug;
10(1):157.
PMID: 39147825
We investigated the biomarker profile of neurodegeneration, Alzheimer's and Lewy body pathology in the CSF of 148 polysomnography-confirmed patients with isolated REM sleep behavior disorder (IRBD), a condition that precedes...
8.
Falgas N, Pena-Gonzalez M, Val-Guardiola A, Perez-Millan A, Guillen N, Sarto J, et al.
Alzheimers Dement
. 2024 Jul;
20(9):6351-6364.
PMID: 39051173
Introduction: Early-onset Alzheimer's disease (EOAD) shows a higher burden of neuropsychiatric symptoms than late-onset Alzheimer's disease (LOAD). We aim to determine the differences in the severity of neuropsychiatric symptoms and...
9.
Alsina R, Riba M, Perez-Millan A, Borrego-Ecija S, Aldecoa I, Romera C, et al.
Acta Neuropathol Commun
. 2024 Jun;
12(1):97.
PMID: 38879502
Wasteosomes (or corpora amylacea) are polyglucosan bodies that appear in the human brain with aging and in some neurodegenerative diseases, and have been suggested to have a potential role in...
10.
Guillen N, Perez-Millan A, Falgas N, Lledo-Ibanez G, Rami L, Sarto J, et al.
Sci Rep
. 2024 Jun;
14(1):12927.
PMID: 38839833
We aimed to characterize the cognitive profile of post-acute COVID-19 syndrome (PACS) patients with cognitive complaints, exploring the influence of biological and psychological factors. Participants with confirmed SARS-CoV-2 infection and...